Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verastem Inc
(NQ:
VSTM
)
3.320
+0.030 (+0.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Verastem Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Verastem Oncology Announces RAMP VS-6766 Clinical Trials and Corporate Updates
October 04, 2022
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
August 08, 2022
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 07, 2022
From
Verastem Oncology
Via
Business Wire
RBC Says Verastem Interim Analysis In Ovarian Cancer Reinforces Enthusiasm
June 07, 2022
Via
Benzinga
Recap: Verastem Q4 Earnings
March 28, 2022
Verastem (NASDAQ:VSTM) reported its Q4 earnings results on Monday, March 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 23, 2022
On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 14, 2022
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (...
Via
Benzinga
Verastem Oncology Provides Update on RAMP 201 Study Evaluating VS-6766 ± Defactinib in Low-Grade Serous Ovarian Cancer
June 06, 2022
From
Verastem Oncology
Via
Business Wire
7 Cheap Biotech Stocks to Buy Now
May 19, 2022
These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains.
Via
InvestorPlace
Verastem Oncology Awarded Pancreatic Cancer Action Network’s First Therapeutic Accelerator Award to Evaluate the Combination of VS-6766 and Defactinib in Front-Line Metastatic Pancreatic Cancer
May 18, 2022
From
Verastem Oncology
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 16, 2022
Via
Benzinga
Verastem Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress
May 09, 2022
From
Verastem Oncology
Via
Business Wire
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
April 21, 2022
The FDA aims to put the PI3K inhibitor drug class under a more stringent regulatory scope as the inhibitor has demonstrated substantial toxicity.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
Gainers
Via
Benzinga
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2022
From
Verastem Oncology
Via
Business Wire
51 Biggest Movers From Thursday
April 18, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...
Via
Benzinga
Verastem Oncology's Return On Capital Employed Insights
March 29, 2022
According to data from Benzinga Pro, during Q4, Verastem Oncology's (NASDAQ:VSTM) reported sales totaled $545.00 thousand. Despite a 27.67% increase in earnings, the company posted a loss of $16.48...
Via
Benzinga
Verastem Announces $150M Debt Financing To Support VS-6766, Defactinib Development
March 28, 2022
Verastem Oncology Inc (NASDAQ: VSTM) entered into a credit facility with Oxford Finance LLC for
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
April 14, 2022
Upgrades
Via
Benzinga
Verastem Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
March 28, 2022
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Provides Financial Update to Support Development of VS-6766 and Defactinib in RAS Pathway-Driven Tumors
March 28, 2022
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Names Preeminent Oncology Researcher Channing Der, PhD, to its Scientific Advisory Board
March 24, 2022
From
Verastem Oncology
Via
Business Wire
Truist Sees 350% Upside On This Cancer-Focused Biopharma Stock - Read Why
March 09, 2022
Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside. Analyst...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2022
March 09, 2022
Upgrades Roth Capital upgraded the previous rating for Hudson Technologies Inc (NASDAQ:HDSN) from Neutral to Buy. For the fourth quarter, Hudson Technologies had an EPS of $0.13,...
Via
Benzinga
87 Biggest Movers From Yesterday
March 10, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 07, 2022
On Monday, 524 stocks hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Taiwan...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 25, 2022
Gainers Surgalign Holdings (NASDAQ:SRGA) ...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 04, 2022
Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market cap stands at $62.7 million. Better Therapeutics (...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 28, 2022
Gainers Enveric Biosciences (NASDAQ:ENVB)...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 25, 2022
Gainers Anixa Biosciences (NASDAQ:ANIX) s...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.